pre-miRNA Information | |
---|---|
pre-miRNA | mmu-mir-122 |
Genomic Coordinates | chr18: 65248861 - 65248926 |
Synonyms | Mirn122a, mmu-mir-122, Mir122a |
Description | Mus musculus miR-122 stem-loop |
Comment | The mature sequence shown here represents the most commonly cloned form from large-scale cloning studies . |
RNA Secondary Structure | ![]() |
Mature miRNA Information | |
---|---|
Mature miRNA | mmu-miR-122-5p |
Sequence | 6| UGGAGUGUGACAAUGGUGUUUG |27 |
Evidence | Experimental |
Experiments | Cloned |
Putative Targets |
Biomarker Information |
|
---|
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | Ppp1r16b | ||||||||||||||||||||
Synonyms | ANKRD4, C130078N17Rik, TIMAP, Wdt4 | ||||||||||||||||||||
Description | protein phosphatase 1, regulatory (inhibitor) subunit 16B | ||||||||||||||||||||
Transcript | NM_001159662 | ||||||||||||||||||||
Other Transcripts | NM_153089 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on Ppp1r16b | |||||||||||||||||||||
3'UTR of Ppp1r16b (miRNA target sites are highlighted) |
>Ppp1r16b|NM_001159662|3'UTR 1 TGTCCTTGAACTGGAGGAGAGAGCTGCCTCGGAGAGGGGCCCCTGGAATCCAAAGCCGGTCCAACAGCTCTGGCTGGCGA 81 GGTGTCGGGGCAGCCGGGGAGAGGTGGGATCTGCTTTCTAGAGGAATGCTGACCTTACCTCATGCCCAGCCGCCCATAGC 161 ATCTCCACTCCCTTCTGTGCTGCTTCCTTGCCTCACTCAATGCCTGCACCTGAAGTATAGCAGGCCGACTCACTCTGCAG 241 TCTGATTCAGGAAGGGTGGGCCTGGGATCTCACTTCTGCACTTGGTAAAGGCTTCTTAGGACCAGGAATATCAACTCCCT 321 ACACACACACACACACACACACACACACACACACACACACACACACACACACATACTCAATTTAGTGTATAAGGATGTTA 401 CACCTGAGCTCTTGGGAAACAAATGAGGCTAAGAACTTGTGGGTTATCCCCAGAAAATGAATGAGTTCAAGACAGTCTTG 481 GCACCACTGCCAACTGGCTTCCACTGGGGAGAGGCCTGCTCAGCGGAGACCCACAGCTCTGAAGTCATACCAGGCTGGGT 561 CACTAGCACACCTAGCAAGAGACAGGAAGTCCTATGGGTTCAGGGAATCCGGGAATCCATACGGATCAGGTTAGTGGGCC 641 CAGGCCTGCTCCCCACAGCCTTGCTGAGAGCTGTTCTCATACATATGTCAATAAGAAAGTGGAGAGTGTTCAAAGGTCAA 721 ACAGGAAAGCCAGGCCATCCATGCTTCTGTGGGAGCACAGGAGTCGGGTTGGGTGCAGCACATTGGTATTTTCCAAACTG 801 TGTTTGGTAAAAGCGTTCTTTCAGGCTGTAAGATCCCAGGTGGGAGGTTCCTGAATTTGCCTTCTCCCAAGATAGTGTCA 881 CACTTGGGTTTTATTGTCTGGTATTTGAGAAATGAATTTCATCAGGAGCTTCCGTGGGGCTAGGGCTCCCAGGGAGAAGG 961 TGAACGCATTGCTGAGAACACCATGGTTAACATTGACATAACAGCATCCTAGCCGGTCTTTGTGGTTTTCCTGCTGTTTT 1041 GGGCCAGCCCATCTCAGCCTGGCCTTCTCAGCCTGAGCCATCCCATCTTTCGGTTGAGGCTTGCACCCTGCCCTCCCACC 1121 TAACAGGATTGAGTCTGCAGAGTGAATGCTCAGGCCCACGCCCCTTCAAGCTTTGCCTTTTCTGTAATGTTGTGTAAGAC 1201 ATGTTTGCCAAGTGTCACTTGTCGGCTCTTGCCAGGAGGTCTCAAAGCTCCCAGCCTGCTGCTTCTGGAGTGGTCATGCC 1281 CAAAGCTGCAAACTGAGGTGCCCGCGGCCACCATCCTGTGCTGCATTCAGGAGAGCATGGCGTGGCTGGAGTTGGCTATC 1361 ATCCCAGCTGTACAGCTTTGCTGCCCCTGTCTTCTTGATGCTGGGAAAGGAAGCCCACACCACATCACCACCATGCTATC 1441 CCACAAAACCGTTGAAATTGTGCCCCGTACCTTGAGTGCGACACACTGGCTCTGCCAAAACCTTCTGGTGTAACTGGCAA 1521 GCTACGAGTTGGTTCCTTGCTCCGTGCTCTTTTTATTTGTCCTCAAACTACCTCCTTAGAGCCCCAAGAGGGTCCCCACG 1601 TCATTCGGATGTATGGGACAGATACTTCTTTACAGCCCCCTATGCCATACCCTTAGTAGGTAGGCTTGCCACTTGTTGGT 1681 CTCTGTCTCCACTGTGGCCTCAGGGCCTCAGTAGACTAGAGATGAATCAGGACCTGACTAGATCTGCAAGATGCTTTATT 1761 AGAACCAGGAGTGTGGGCCAGAGAGCACCCTGAAGGCTGCTGGATGCAGAAGGAGGTGCACAACACTAGGTCATCTCCAC 1841 CCCAACTCCAGGACAGATGGAATCCGGCATGGTGCAATAACATAAGAGACTAAAGACAGTTTCTGGGATCCCTGGGGGCT 1921 CAGCTAGGCTCTGTAGCCCATAGCTGAAAGAGGAGATGGTCAAAACACACACCTGTGGCTTTAAACATTTAGCTCTGACA 2001 GACACTGAAATGCCTCTGGAGATGATTTTAGCCACAAGGTGGGCAGTTGCCCAGGCAGCCAGCTACATACTCTTAGGAGT 2081 CAGCTGCCCAGGGTTTCTGAGCTCTGTGCTCAGGGGCCAGAGAATGAAGGCATTTATTGCCATCTCTGAGCCATTCAGGC 2161 CATCTCTTCACACCCAGCACTTCTTCCTGCCTCCTGGACCGTTCTTCTCTACCTGAGGGGTGGGAAACTCGGCTGCCTCC 2241 TGCATGGGAGCTAGTCCCAGACGGTGTGGACTCATGGGCTTTTGTTCATGTTTTCCACTAGGGATAAACAAATGTTCCCT 2321 GTTCAGGCTCCAAGTCCCCAGGGCACTTTGTGACTCTTTGGAATATTGAGAGTCACAATGAGGAACAGTCTCCAGCGCAT 2401 GAGCCAGGGCCACCCACCCATTCACTCATGTGATCGATCTATTGAGGTGCTGAGACACACCCGATGCGCTGTTAGTTTCA 2481 GCAGATAATGGACTAACCTGGCAGTGAAGACTTTGATCTCTTGAGGACCGTGGGCATCCCCGGACTCATCTATTATTCTA 2561 ATCAGAGTGCCTCCATGCCAGACCAGTGTCCCCCGTGCTTTGCCGCACCTGCAGTTCTTAAGAGTGTGAATCTCTTTATC 2641 TGGGAGACAGCTTTCTGACCACTCCTAGATAACATTTGCCACTAAGTGCAGAGGCTAGATCTCAGGTACCAGGCAGACAT 2721 TATACAGGTCCATCTAGATAGAGCCTTCAGAGGTAGCCTTCAGGCCAGCATCCATGGAGAACAATACAACAGCAGTCTAA 2801 GGTCAGTGCCTGGAAGAACCAGAAGTCTGCAATTTGCTGTCAAATACATCCCTAGCATTTACAGTCCTCTCCTGCTTGTT 2881 TTTTGCTCATGAATCATACAGTCTTCTCCCCTACACCACCAATGGGTGTTGGGAGGGAGAACAACTACTTCTCTTCTTTT 2961 TTTTTTTTTTTTTTTTTTTTTTTTTTTAAAGATTTATTTATTTATTTATTATATGTAAGTACACTGTAGCTGTCTTCAGA 3041 CACTCCAGAAGAGGGAGTCAGATCTCATTATGGGTGGTTGTAAGCCACCATGTGGTTGCTGGGATTTGAACTTCGAACCT 3121 TCGGAAGAGCAGTCGGGTGCTCTTACCCACTGAGCCATCTCACCAGCCCACTACTTCTCTTCAAATTAAACATTTCCATG 3201 TGTGTCAGCCTCTCTCCCTGGAAGATGTGGATCCAAGGGCTAGGAGAAGCCTGGCAAGGTTGACCAGATGGCTCACTCCT 3281 ACTGAAGACATCTATTTCCAAACCAGGTGCCCTGCAGTTCCCTGTGAGCTGTGGTTCCTTGCACCCACCTATGCTCCCCA 3361 AACTATTAGAAATTGGTAGCTATCACCAGATTGTGAATTTCTGGCCAGTAGCTCAGGGAATTGGAATGAATCCTAAACCC 3441 AGGTCTACTGAAGACTTTGGGGACATAATTCTTTATCAAATATACAGCATTAATGAAGCTTCTCTGTACTATTTGATTAA 3521 CTTGTAGACTTTTGAGAAGCTTGCCAGAGTGTGTCCCTCAGCCAGGTGTAGTGGCACACATCTTTAATCCCAGCACATAG 3601 GCGGCAGAGGCAAGTGGTTGTATTTCTGAGTTCCAAGCCAGCCTGGTCTACAGAGTGAGTTCTAGGCTAGCCAGGGCTAC 3681 TCAGAGAAACCTTGTCTCCAAAAAACCAAATAAAAAATAAAATAAAATATGGCCTCTGGGTTGGGTTAACACAGTCTAGC 3761 TTTGTAACAATGTGAGACTCTTGGTTCTTAGTGTTCTATACCCTCTGGTTCTGGGCGTTGTCTCCCACCTGTTCTTCTAA 3841 AGCAGGATATTGGGATATTTTCCAGAGGGGCCATCCTTACACGATGTTGGGACTGTCTGAACTGTCGCTATTTGTAGCCT 3921 GGTGATATCCCCTTCTTCCCCAGGGCACAGAAAAGCCAAGGGTCATATGGCCAGGGCCAACAGCTCCACTAAAGTGACCC 4001 ACCACTTTTCTAGAAAGCCCGAGACCTCTCCCTTGTTGACCAGAGGGCCTGCTTCTCATGGGCACTTCAAATGCCACTGT 4081 GCGGGGCCTGGCTCTGCATACCTAGGAAAAGTCTGCAGACACCCAGCCCTCCGCAATAATTCACCAGACCAGAAGCCACT 4161 GATGTACAGAGAACACTTAAGAAAAAAAAATGTATTTTATGTGAAAAAAAAGTTAAAACTCTGTATACTGTATCAGCAGC 4241 TTTGTGTAAAAAATGGCAATCAAAAGAGTCTAATATATTTAAAACTTTTTTAAAAAAATATTCTCATGGATCTTTGATAT 4321 CGTTCTGAAGCAGCTCCATGCCTCCAAGATGGGGTCTGACCATGTCACCAAGGGGCCTGTGCCTCTGGAGTTACTTCCAG 4401 CTGCCAAGGCCTGTGACGGAATTCATTGCTATGGATTTTTAATTAAGATTATTAAATTCCTTTTAATAACA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
Experimental Support 1 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | mESCs | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
HITS-CLIP data was present in GSM622571. RNA binding protein: AGO2. Condition:WT1B
... - Leung AK; Young AG; Bhutkar A; Zheng GX; et al., 2011, Nature structural & molecular biology. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Leung AK; Young AG; Bhutkar A; Zheng GX; et al. - Nature structural & molecular biology, 2011
MicroRNAs (miRNAs) are 19-22-nucleotide noncoding RNAs that post-transcriptionally regulate mRNA targets. We have identified endogenous miRNA binding sites in mouse embryonic stem cells (mESCs), by performing photo-cross-linking immunoprecipitation using antibodies to Argonaute (Ago2) followed by deep sequencing of RNAs (CLIP-seq). We also performed CLIP-seq in Dicer(-)/(-) mESCs that lack mature miRNAs, allowing us to define whether the association of Ago2 with the identified sites was miRNA dependent. A significantly enriched motif, GCACUU, was identified only in wild-type mESCs in 3' untranslated and coding regions. This motif matches the seed of a miRNA family that constitutes ~68% of the mESC miRNA population. Unexpectedly, a G-rich motif was enriched in sequences cross-linked to Ago2 in both the presence and absence of miRNAs. Expression analysis and reporter assays confirmed that the seed-related motif confers miRNA-directed regulation on host mRNAs and that the G-rich motif can modulate this regulation.
LinkOut: [PMID: 21258322]
|
86 mmu-miR-122-5p Target Genes:
Functional analysis:
ID![]() |
Target | Description | Validation methods |
![]() |
![]() |
|||||||
Strong evidence | Less strong evidence | |||||||||||
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
|||||
MIRT003075 | Tmem50b | transmembrane protein 50B | ![]() |
1 | 1 | |||||||
MIRT003076 | Lass6 | ceramide synthase 6 | ![]() |
1 | 1 | |||||||
MIRT003077 | Gpx7 | glutathione peroxidase 7 | ![]() |
1 | 1 | |||||||
MIRT003113 | Tgfbr1 | transforming growth factor, beta receptor I | ![]() |
![]() |
![]() |
3 | 1 | |||||
MIRT003114 | Sbk1 | SH3-binding kinase 1 | ![]() |
![]() |
![]() |
3 | 1 | |||||
MIRT003117 | Hist1h1c | histone cluster 1, H1c | ![]() |
![]() |
![]() |
3 | 1 | |||||
MIRT003118 | Ddc | dopa decarboxylase | ![]() |
![]() |
2 | 1 | ||||||
MIRT003120 | Rell1 | RELT-like 1 | ![]() |
![]() |
![]() |
3 | 1 | |||||
MIRT003121 | Bach1 | BTB and CNC homology 1, basic leucine zipper transcription factor 1 | ![]() |
![]() |
2 | 1 | ||||||
MIRT003122 | Apob | apolipoprotein B | ![]() |
![]() |
2 | 1 | ||||||
MIRT003123 | P4ha1 | procollagen-proline, 2-oxoglutarate 4-dioxygenase (proline 4-hydroxylase), alpha 1 polypeptide | ![]() |
![]() |
2 | 1 | ||||||
MIRT003124 | Ccng1 | cyclin G1 | ![]() |
![]() |
2 | 1 | ||||||
MIRT003125 | Slc7a1 | solute carrier family 7 (cationic amino acid transporter, y+ system), member 1 | ![]() |
![]() |
![]() |
3 | 3 | |||||
MIRT003126 | Gys1 | glycogen synthase 1, muscle | ![]() |
![]() |
2 | 2 | ||||||
MIRT003127 | Slc35a4 | solute carrier family 35, member A4 | ![]() |
![]() |
2 | 2 | ||||||
MIRT003128 | Hfe2 | hemochromatosis type 2 (juvenile) | ![]() |
![]() |
![]() |
3 | 3 | |||||
MIRT003129 | Tmed3 | transmembrane p24 trafficking protein 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT003132 | Bckdk | branched chain ketoacid dehydrogenase kinase | ![]() |
![]() |
![]() |
![]() |
4 | 1 | ||||
MIRT003133 | Aldoa | aldolase A, fructose-bisphosphate | ![]() |
![]() |
![]() |
![]() |
4 | 7 | ||||
MIRT003134 | Ndrg3 | N-myc downstream regulated gene 3 | ![]() |
![]() |
![]() |
![]() |
4 | 2 | ||||
MIRT003135 | Cd320 | CD320 antigen | ![]() |
![]() |
![]() |
![]() |
4 | 1 | ||||
MIRT003724 | Smarcd1 | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 1 | ![]() |
![]() |
![]() |
3 | 1 | |||||
MIRT003725 | Rcan1 | regulator of calcineurin 1 | ![]() |
![]() |
2 | 1 | ||||||
MIRT003726 | Gde1 | glycerophosphodiester phosphodiesterase 1 | ![]() |
![]() |
2 | 1 | ||||||
MIRT004536 | Ccrn4l | nocturnin | ![]() |
![]() |
![]() |
![]() |
4 | 1 | ||||
MIRT005975 | Klf6 | Kruppel-like factor 6 | ![]() |
![]() |
![]() |
![]() |
4 | 1 | ||||
MIRT005976 | B2m | beta-2 microglobulin | ![]() |
1 | 1 | |||||||
MIRT005977 | Afp | alpha fetoprotein | ![]() |
1 | 1 | |||||||
MIRT005978 | Ccl2 | chemokine (C-C motif) ligand 2 | ![]() |
1 | 1 | |||||||
MIRT005979 | Csf3r | colony stimulating factor 3 receptor (granulocyte) | ![]() |
1 | 1 | |||||||
MIRT005980 | Ctgf | connective tissue growth factor | ![]() |
1 | 1 | |||||||
MIRT005981 | Cxcl13 | chemokine (C-X-C motif) ligand 13 | ![]() |
1 | 1 | |||||||
MIRT005982 | Cyp2b13 | cytochrome P450, family 2, subfamily b, polypeptide 13 | ![]() |
1 | 1 | |||||||
MIRT005983 | Dbp | D site albumin promoter binding protein | ![]() |
1 | 1 | |||||||
MIRT005984 | Igf2 | insulin-like growth factor 2 | ![]() |
1 | 1 | |||||||
MIRT005985 | Il1b | interleukin 1 beta | ![]() |
1 | 1 | |||||||
MIRT005986 | Jun | jun proto-oncogene | ![]() |
1 | 1 | |||||||
MIRT005987 | Per1 | period circadian clock 1 | ![]() |
1 | 1 | |||||||
MIRT005988 | Alpl | alkaline phosphatase, liver/bone/kidney | ![]() |
![]() |
2 | 1 | ||||||
MIRT005989 | Cs | citrate synthase | ![]() |
![]() |
2 | 1 | ||||||
MIRT005990 | Prom1 | prominin 1 | ![]() |
![]() |
![]() |
3 | 1 | |||||
MIRT005991 | Sox4 | SRY (sex determining region Y)-box 4 | ![]() |
![]() |
![]() |
3 | 1 | |||||
MIRT013527 | Uros | uroporphyrinogen III synthase | ![]() |
1 | 1 | |||||||
MIRT013528 | Ppox | protoporphyrinogen oxidase | ![]() |
1 | 1 | |||||||
MIRT013529 | Urod | uroporphyrinogen decarboxylase | ![]() |
1 | 1 | |||||||
MIRT013530 | Cpox | coproporphyrinogen oxidase | ![]() |
1 | 1 | |||||||
MIRT013531 | Fech | ferrochelatase | ![]() |
1 | 1 | |||||||
MIRT013532 | Hamp | hepcidin antimicrobial peptide | ![]() |
1 | 1 | |||||||
MIRT013533 | Tfr2 | transferrin receptor 2 | ![]() |
1 | 1 | |||||||
MIRT013534 | Smad4 | SMAD family member 4 | ![]() |
1 | 1 | |||||||
MIRT013535 | Smad7 | SMAD family member 7 | ![]() |
1 | 1 | |||||||
MIRT013536 | Bmpr1a | bone morphogenetic protein receptor, type 1A | ![]() |
1 | 1 | |||||||
MIRT013537 | Hba-a1 | hemoglobin alpha, adult chain 1 | ![]() |
![]() |
2 | 1 | ||||||
MIRT013538 | Hmbs | hydroxymethylbilane synthase | ![]() |
![]() |
2 | 1 | ||||||
MIRT013539 | Mir17 | microRNA 17 | ![]() |
![]() |
2 | 1 | ||||||
MIRT013540 | Alas2 | aminolevulinic acid synthase 2, erythroid | ![]() |
![]() |
2 | 1 | ||||||
MIRT013541 | Mir451 | microRNA 451a | ![]() |
![]() |
2 | 1 | ||||||
MIRT013542 | Tfrc | transferrin receptor | ![]() |
![]() |
2 | 1 | ||||||
MIRT013543 | Socs2 | suppressor of cytokine signaling 2 | ![]() |
1 | 1 | |||||||
MIRT013544 | Slc35g1 | solute carrier family 35, member G1 | ![]() |
1 | 1 | |||||||
MIRT013545 | Camk2b | calcium/calmodulin-dependent protein kinase II, beta | ![]() |
1 | 1 | |||||||
MIRT013546 | Irf6 | interferon regulatory factor 6 | ![]() |
1 | 1 | |||||||
MIRT013547 | Rbl2 | RB transcriptional corepressor like 2 | ![]() |
1 | 1 | |||||||
MIRT013548 | Hfe | hemochromatosis | ![]() |
![]() |
2 | 1 | ||||||
MIRT013549 | Ccnd1 | cyclin D1 | ![]() |
![]() |
2 | 1 | ||||||
MIRT054338 | Pkm | pyruvate kinase, muscle | ![]() |
![]() |
![]() |
3 | 1 | |||||
MIRT054339 | Tfdp2 | transcription factor Dp 2 | ![]() |
![]() |
![]() |
3 | 1 | |||||
MIRT054340 | E2f1 | E2F transcription factor 1 | ![]() |
![]() |
![]() |
3 | 1 | |||||
MIRT579817 | Zfp113 | zinc finger protein 113 | ![]() |
1 | 1 | |||||||
MIRT580378 | Tmem206 | transmembrane protein 206 | ![]() |
1 | 2 | |||||||
MIRT581166 | Sec23ip | Sec23 interacting protein | ![]() |
1 | 1 | |||||||
MIRT582514 | March5 | membrane-associated ring finger (C3HC4) 5 | ![]() |
1 | 2 | |||||||
MIRT586941 | H2-T24 | histocompatibility 2, T region locus 24 | ![]() |
1 | 2 | |||||||
MIRT591859 | Iffo2 | intermediate filament family orphan 2 | ![]() |
1 | 1 | |||||||
MIRT592160 | Paxip1 | PAX interacting (with transcription-activation domain) protein 1 | ![]() |
1 | 1 | |||||||
MIRT592189 | Nanog | Nanog homeobox | ![]() |
1 | 2 | |||||||
MIRT592792 | Cdh12 | cadherin 12 | ![]() |
1 | 1 | |||||||
MIRT597026 | Thap1 | THAP domain containing, apoptosis associated protein 1 | ![]() |
1 | 1 | |||||||
MIRT597210 | Snhg11 | small nucleolar RNA host gene 11 | ![]() |
1 | 1 | |||||||
MIRT601300 | Zfp949 | zinc finger protein 949 | ![]() |
1 | 1 | |||||||
MIRT602608 | Chrna1 | cholinergic receptor, nicotinic, alpha polypeptide 1 (muscle) | ![]() |
1 | 1 | |||||||
MIRT602960 | Xpo7 | exportin 7 | ![]() |
1 | 1 | |||||||
MIRT603391 | Sgol2 | shugoshin 2A | ![]() |
1 | 1 | |||||||
MIRT604008 | Ggps1 | geranylgeranyl diphosphate synthase 1 | ![]() |
1 | 1 | |||||||
MIRT605553 | Ppp1r16b | protein phosphatase 1, regulatory (inhibitor) subunit 16B | ![]() |
1 | 1 | |||||||
MIRT606204 | Sfxn4 | sideroflexin 4 | ![]() |
1 | 1 |
miRNA-Drug Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|